Endolimax Nana
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Entamoeba Histolytica
Journal of Clinical Microbiology and Biochemical Technology Piotr Nowak1*, Katarzyna Mastalska1 Review Article and Jakub Loster2 1Laboratory of Parasitology, Department of Microbiology, University Hospital in Krakow, 19 Entamoeba Histolytica - Pathogenic Kopernika Street, 31-501 Krakow, Poland 2Department of Infectious Diseases, University Protozoan of the Large Intestine in Hospital in Krakow, 5 Sniadeckich Street, 31-531 Krakow, Poland Humans Dates: Received: 01 December, 2015; Accepted: 29 December, 2015; Published: 30 December, 2015 *Corresponding author: Piotr Nowak, Laboratory of Abstract Parasitology, Department of Microbiology, University Entamoeba histolytica is a cosmopolitan, parasitic protozoan of human large intestine, which is Hospital in Krakow, 19 Kopernika Street, 31- 501 a causative agent of amoebiasis. Amoebiasis manifests with persistent diarrhea containing mucus Krakow, Poland, Tel: +4812/4247587; Fax: +4812/ or blood, accompanied by abdominal pain, flatulence, nausea and fever. In some cases amoebas 4247581; E-mail: may travel through the bloodstream from the intestine to the liver or to other organs, causing multiple www.peertechz.com abscesses. Amoebiasis is a dangerous, parasitic disease and after malaria the second cause of deaths related to parasitic infections worldwide. The highest rate of infections is observed among people living Keywords: Entamoeba histolytica; Entamoeba in or traveling through the tropics. Laboratory diagnosis of amoebiasis is quite difficult, comprising dispar; Entamoeba moshkovskii; Entamoeba of microscopy and methods of molecular biology. Pathogenic species Entamoeba histolytica has to histolytica sensu lato; Entamoeba histolytica sensu be differentiated from other nonpathogenic amoebas of the intestine, so called commensals, that stricto; commensals of the large intestine; amoebiasis very often live in the human large intestine and remain harmless. -
The Intestinal Protozoa
The Intestinal Protozoa A. Introduction 1. The Phylum Protozoa is classified into four major subdivisions according to the methods of locomotion and reproduction. a. The amoebae (Superclass Sarcodina, Class Rhizopodea move by means of pseudopodia and reproduce exclusively by asexual binary division. b. The flagellates (Superclass Mastigophora, Class Zoomasitgophorea) typically move by long, whiplike flagella and reproduce by binary fission. c. The ciliates (Subphylum Ciliophora, Class Ciliata) are propelled by rows of cilia that beat with a synchronized wavelike motion. d. The sporozoans (Subphylum Sporozoa) lack specialized organelles of motility but have a unique type of life cycle, alternating between sexual and asexual reproductive cycles (alternation of generations). e. Number of species - there are about 45,000 protozoan species; around 8000 are parasitic, and around 25 species are important to humans. 2. Diagnosis - must learn to differentiate between the harmless and the medically important. This is most often based upon the morphology of respective organisms. 3. Transmission - mostly person-to-person, via fecal-oral route; fecally contaminated food or water important (organisms remain viable for around 30 days in cool moist environment with few bacteria; other means of transmission include sexual, insects, animals (zoonoses). B. Structures 1. trophozoite - the motile vegetative stage; multiplies via binary fission; colonizes host. 2. cyst - the inactive, non-motile, infective stage; survives the environment due to the presence of a cyst wall. 3. nuclear structure - important in the identification of organisms and species differentiation. 4. diagnostic features a. size - helpful in identifying organisms; must have calibrated objectives on the microscope in order to measure accurately. -
The Nutrition and Food Web Archive Medical Terminology Book
The Nutrition and Food Web Archive Medical Terminology Book www.nafwa. -
6.5 X 11 Double Line.P65
Cambridge University Press 978-0-521-53026-2 - The Cambridge Historical Dictionary of Disease Edited by Kenneth F. Kiple Index More information Name Index A Baillie, Matthew, 80, 113–14, 278 Abercrombie, John, 32, 178 Baillou, Guillaume de, 83, 224, 361 Abreu, Aleixo de, 336 Baker, Brenda, 333 Adams, Joseph, 140–41 Baker, George, 187 Adams, Robert, 157 Balardini, Lodovico, 243 Addison, Thomas, 22, 350 Balfour, Francis, 152 Aesculapius, 246 Balmis, Francisco Xavier, 303 Aetius of Amida, 82, 232, 248 Bancroft, Edward, 364 Afzelius, Arvid, 203 Bancroft, Joseph, 128 Ainsworth, Geoffrey C., 128–32, 132–34 Bancroft, Thomas, 87, 128 Albert, Jose, 48 Bang, Bernhard, 60 Alexander of Tralles, 135 Bannwarth, A., 203 Alibert, Jean Louis, 147, 162, 359 Bard, Samuel, 83 Ali ibn Isa, 232 Barensprung,¨ F. von, 360 Allchin, W. H., 177 Bargen, J. A., 177 Allison, A. C., 25, 300 Barker, William H., 57–58 Allison, Marvin J., 70–71, 191–92 Barthelemy,´ Eloy, 31 Alpert, S., 178 Bartlett, Elisha, 351 Altman, Roy D., 238–40 Bartoletti, Fabrizio, 103 Alzheimer, Alois, 14, 17 Barton, Alberto, 69 Ammonios, 358 Bartram, M., 328 Amos, H. L., 162 Bassereau, Leon,´ 317 Andersen, Dorothy, 84 Bateman, Thomas, 145, 162 Anderson, John, 353 Bateson, William, 141 Andral, Gabriel, 80 Battistine, T., 69 Annesley, James, 21 Baumann, Eugen, 149 Arad-Nana, 246 Beard, George, 106 Archibald, R. G., 131 Beet, E. A., 24, 25 Aretaeus the Cappadocian, 80, 82, 88, 177, 257, 324 Behring, Emil, 95–96, 325 Aristotle, 135, 248, 272, 328 Bell, Benjamin, 152 Armelagos, George, 333 Bell, J., 31 Armstrong, B. -
Amoebic Dysentery
University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1934 Amoebic dysentery H. C. Dix University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Part of the Medical Education Commons Recommended Citation Dix, H. C., "Amoebic dysentery" (1934). MD Theses. 320. https://digitalcommons.unmc.edu/mdtheses/320 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. A MOE B leD Y SEN T E R Y By H. c. Dix University of Nebraska College of Medicine Omaha, N~braska April 1934 Preface This paper is presented to the University of Nebraska College of MediCine to fulfill the senior requirements. The subject of amoebic dysentery wa,s chosen due to the interest aroused from the previous epidemic, which started in Chicago la,st summer (1933). This disea,se has previously been considered as a tropical disease, B.nd was rarely seen and recognized in the temperate zone. Except in indl vidu8,ls who had been in the tropics previously. In reviewing the literature, I find that amoebio dysentery may be seen in any part of the world, and from surveys made, the incidence is five in every hun- dred which harbor the Entamoeba histolytlca, it being the only pathogeniC amoeba of the human gastro-intes tinal tract. -
Enteric Protozoa in the Developed World: a Public Health Perspective
Enteric Protozoa in the Developed World: a Public Health Perspective Stephanie M. Fletcher,a Damien Stark,b,c John Harkness,b,c and John Ellisa,b The ithree Institute, University of Technology Sydney, Sydney, NSW, Australiaa; School of Medical and Molecular Biosciences, University of Technology Sydney, Sydney, NSW, Australiab; and St. Vincent’s Hospital, Sydney, Division of Microbiology, SydPath, Darlinghurst, NSW, Australiac INTRODUCTION ............................................................................................................................................420 Distribution in Developed Countries .....................................................................................................................421 EPIDEMIOLOGY, DIAGNOSIS, AND TREATMENT ..........................................................................................................421 Cryptosporidium Species..................................................................................................................................421 Dientamoeba fragilis ......................................................................................................................................427 Entamoeba Species.......................................................................................................................................427 Giardia intestinalis.........................................................................................................................................429 Cyclospora cayetanensis...................................................................................................................................430 -
Entamoeba Histolytica—Gut Microbiota Interaction: More Than Meets the Eye
microorganisms Review Entamoeba histolytica—Gut Microbiota Interaction: More Than Meets the Eye Serge Ankri Department of Molecular Microbiology, Ruth and Bruce Rappaport Faculty of Medicine, Haifa 31096, Israel; [email protected] Abstract: Amebiasis is a disease caused by the unicellular parasite Entamoeba histolytica. In most cases, the infection is asymptomatic but when symptomatic, the infection can cause dysentery and invasive extraintestinal complications. In the gut, E. histolytica feeds on bacteria. Increasing evidences support the role of the gut microbiota in the development of the disease. In this review we will discuss the consequences of E. histolytica infection on the gut microbiota. We will also discuss new evidences about the role of gut microbiota in regulating the resistance of the parasite to oxidative stress and its virulence. Keywords: gut microbiota; entamoeba histolytica; resistance to oxidative stress; resistance to nitrosative stress; virulence 1. Introduction Amebiasis is caused by the protozoan parasite Entamoeba histolytica. This disease is a significant hazard in underdeveloped countries with reduced socioeconomic and poor Citation: Ankri, S. Entamoeba sanitation. It is assessed that amebiasis accounted for 55,500 deaths and 2.237 million histolytica—Gut Microbiota disability-adjusted life years (the sum of years of life lost and years lived with disability) Interaction: More Than Meets the Eye. in 2010 [1]. Amebiasis has also been diagnosed in tourists from developed countries who Microorganisms 2021, 9, 581. return from vacation in endemic regions. Inflammation of the large intestine and liver https://doi.org/10.3390/ abscess represent the main clinical manifestations of amebiasis. Amebiasis is caused by the microorganisms9030581 ingestion of food contaminated with cysts, the infective form of the parasite. -
Entamoeba Histolytica?
Amebas Friend and foe Facultative Pathogenicity of Entamoeba histolytica? Confusing History 1875 Lösch correlated dysentery with amebic trophozoites 1925 Brumpt proposed two species: E. dysenteriae and E. dispar 1970's biochemical differences noted between invasive and non-invasive isolates 80's/90's several antigenic and DNA differences demonstrated • rRNA 2.2% sequence difference 1993 Diamond and Clark proposed a new species (E. dispar) to describe non-invasive strains 1997 WHO accepted two species 1 Family Entamoebidae Family includes parasites • Entamoeba histolytica and commensals • Entamoeba dispar • Entamoeba coli Species are differentiated • Entamoeba hartmanni based on size, nuclear • Endolimax nana substructures • Iodamoeba bütschlii Entamoeba histolytica one of the most potent killers in nature Entamoeba histolytica • worldwide distribution (cosmopolitan) • higher prevalence in tropical or developing countries (20%) • 1-6% in temperate countries • Possible animal reservoirs • Amebiasis - Amebic dysentery • aka: Montezuma’s revenge Taxonomy • One parasitic species? • E. histolytica • E. dispar • E. hartmanni 2 Entamoeba Life Cycle - Direct Fecal/Oral transmission Cyst - Infective stage Resistant form Trophozoite - feeding, binary fission Different stages of cyst development Precysts - rich in glycogen Young cyst - 2, then 4 nuclei with chromotoid bodies Metacysts - infective stage Metacystic trophozoite - 8 8 Excystation Metacyst Cyst wall disruption Ameba emerges Nuclear division 48 Cytokinesis Nuclear division -
38 Entamoeba Histolytica and Other Rhizophodia
MODULE Entamoeba Histolytica and Other Rhizophodia Microbiology 38 Notes ENTAMOEBA HISTOLYTICA AND OTHER RHIZOPHODIA 38.1 INTRODUCTION Amoebae can be pathogenic called Entamoeba histolytica and non pathogenic called Entamoeba coli (large intestines), Entamoeba gingivalis (oral cavity). These parasites are motile with pseudopodia. The pseudopodia are cytoplasmic processes which are thrown out. OBJECTIVES After reading this lesson you will be able to: z describe morphology, its life cycle, pathogenecity of Entameba Histolytica, other amoebae and free living amoeba z differentiate between amoebic and Bacillary dysentery z differentiate between Entamoeba Histolytica and Entamoeba Coli z demonstrate Laboratory diagnosis of Entameba 38.2 ENTAMOEBA HISTOLYTICA It belongs to the class Rhizopoda and family Entamoebidae. It is the causative agent of amoebiasis. Amoebiasis can be intestinal and extra intestinal like amoebic hepatitis, amoebic liver abscess. 38.3 MORPHOLOGY The Entamoeba is seen in three stages 344 MICROBIOLOGY Entamoeba Histolytica and Other Rhizophodia MODULE (a) Trophozoite: The trophozoite is 18-40 µm in size. The trophozoite is Microbiology actively motile. The cytoplasm is demarcated into endoplasm and ectoplasm. Ingested food particles and red blood cells are seen in the cytoplasm No bacteria are seen in the cytoplasm. The nucleus is 6-15 µm and has a central rounded karyosome. Nuclear membrane has chromatin granules and spoke like radial arrangement of chromatin fibrils. Notes Fig. 38.1 (b) Precyst: Smaller in size. 10-20 µm in diameter. It is round to oval in shape with blunt pseudopodium. The nuclei is similar to the trophozoite. (c) Cyst: These are round 10-15 µm in diameter. It is surrounded by a refractile membrane called as the cyst wall. -
Developing Novel Therapeutic Agents for Acanthamoeba Infection and Investigating the Process of Encystment
Developing novel therapeutic agents for Acanthamoeba infection and investigating the process of encystment Anas Abdullah Hamad (BSc, MSc) A thesis submitted in partial fulfilment of the requirements of the University of Wolverhampton for the degree of Doctor of Philosophy June 2020 Declaration This work or any part thereof has not previously been presented in any form to the University or to any other body whether for the purposes of assessment, publication or for any other purpose (unless otherwise indicated in page 3). Save for any express acknowledgements, references and/or bibliographies cited in the work, I confirm that the intellectual content of the work is the result of my own efforts and of no other person. The right of Anas Abdullah Hamad to be identified as author of this work is asserted in accordance with ss.77 and 78 of the Copyright, Designs and Patents Act 1988. At this date copyright is owned by the author. Signature………………………………………. Date……………………………………………. 15/10/2020 2 List of posters and publication related to the work presented in this thesis: Heaselgrave, W., Hamad, A., Coles, S. and Hau, S., 2019. In Vitro Evaluation of the Inhibitory Effect of Topical Ophthalmic Agents on Acanthamoeba Viability. Translational vision science & technology, 8(5), pp.17-17. Manuscript published. Hamad, A. and Heaselgrave, W., 2017. Developing novel treatments for the blinding protozoan eye infection Acanthamoeba keratitis. Proceedings of the Internal Annual Research Symposium, Poster no. 23, University of Wolverhampton, UK. Hamad, A. and Heaselgrave, W., 2018. Developing new treatments and optimising existing treatment strategies for the corneal infection Acanthamoeba keratitis. -
Granulomatous Meningoencephalitis Balamuthia Mandrillaris in Peru: Infection of the Skin and Central Nervous System
SMGr up Granulomatous Meningoencephalitis Balamuthia mandrillaris in Peru: Infection of the Skin and Central Nervous System A. Martín Cabello-Vílchez MSc, PhD* Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical “Alexander von Humboldt” *Corresponding author: Instituto de Medicina Tropical “Alexander von Humboldt”, Av. Honorio Delgado Nº430, San A. Martín Cabello-Vílchez, Universidad Peruana Cayetano Heredia, MartínPublished de Porras, Date: Lima-Perú, Tel: +511 989767619, Email: [email protected] February 16, 2017 ABSTRACT Balamuthia mandrillaris is an emerging cause of sub acute granulomatous amebic encephalitis (GAE) or Balamuthia mandrillaris amoebic infection (BMAI). It is an emerging pathogen causing skin lesions as well as CNS involvement with a fatal outcome if untreated. The infection has been described more commonly in inmunocompetent individuals, mostly males, many children. All continents have reported the disease, although a majority of cases are seen in North and South America, especially Peru. Balamuthia mandrillaris is a free living amoeba that can be isolated from soil. In published reported cases from North America, most patients will debut with neurological symptoms, where as in countries like Peru, a skin lesion will precede neurological symptoms. The classical cutaneous lesionis a plaque, mostly located on face, knee or other body parts. Diagnosis requires a specialized laboratory and clinical experience. This Amoebic encephalitis may be erroneously interpreted as a cerebral neoplasm, causing delay in the management of the infection. Thediagnosis of this infection has proven to be difficult and is usually made post-mortem but in Peru many cases were pre-morten. Despite case fatality rates as high as > 98%, some experimental therapies have shown protozoal therapy with macrolides and phenothiazines. -
Archezoa and the Origin of Eukaryotes Patrick J
Problems and paradigms A kingdom’s progress: Archezoa and the origin of eukaryotes Patrick J. Keeling* Summary The taxon Archezoa was proposed to unite a group of very odd eukaryotes that lack many of the characteristics classically associated with nucleated cells, in particular the mitochondrion. The hypothesis was that these cells diverged from other eukaryotes before these characters ever evolved, and therefore they repre- sent ancient and primitive eukaryotic lineages. The kingdom comprised four groups: Metamonada, Microsporidia, Parabasalia, and Archamoebae. Until re- cently, molecular work supported their primitive status, as they consistently branched deeply in eukaryotic phylogenetic trees. However, evidence has now emerged that many Archezoa contain genes derived from the mitochondrial symbiont, revealing that they actually evolved after the mitochondrial symbiosis. In addition, some Archezoa have now been shown to have evolved more recently than previously believed, especially the Microsporidia for which considerable evidence now indicates a relationship with fungi. In summary, the mitochondrial symbiosis now appears to predate all Archezoa and perhaps all presently known eukaryotes. BioEssays 20:87–95, 1998. 1998 John Wiley & Sons, Inc. INTRODUCTION cyanobacteria and they also lack flagella and basal bodies Prior to the popularization of the endosymbiotic theory, it was (for discussion see Ref. 1). However, according to the widely believed that the evolutionary link between prokary- endosymbiotic theory, the reason photosynthesis is so simi- otes and eukaryotes was the presence of photosynthesis in lar in cyanobacteria and photosynthetic eukaryotes is that cyanobacteria and algae. The biochemistry of oxygenic the plastids of plant and algal cells are derived from a photosynthesis was considered too complicated and too cyanobacterial symbiont.